Respiratory therapy with intermittent positive pressure breathing (IPPB therapy) is a recognized treatment concept for obstructive respiratory disease. In case of heavily reduced ventilation reserves or pronounced respiratory failure, it is recommended to administer aerosols through inhalation. The slow, deep inspiration supported by the respiratory therapy device always improves pulmonary ventilation, gas exchange, and aerosol deposition. The optional, adjustable exhalation stricture, which can be adjusted at the db 3000, contributes to this as well by ensuring that poorly ventilated peripheral lung segments receive a better gas supply. This in turn has prophylactic effects, since good ventilation is the best preventative measure against infection. Furthermore, IPPB therapy can be supplemented with drug nebulization, such as bronchospasmolytic or secretolytic substances, for obstructive diseases.
Another positive effect of IPPB therapy is the cough reflex it provokes, which can significantly improve the bronchial hygiene and secretolysis of patients. db 3000 is designed for general care units or home care. Thanks to its simple handling and compact design, the device allows for direct implementation of medically prescribed respiratory therapy. In addition to portable respiratory and aerosol therapy devices for home use - the db 3000 - the alpha product family also includes two clinical versions, which are designed to add oxygen from the central gas supply: db 3100 and db 3200. As a consequence, the devices are perfectly suited to provide continued IPPB therapy for recruitment, secretion management, and drug nebulization in acute care as well as physiotherapy and general care.
- Application in general care units and in home care
- Suitable for applications involving IPPB therapy